Early Detection Research Network

CancerSEEK

Aliases:
This biomarker is also known as:
  • CancerSEEK,

Description…

Detection of genetic mutations associated with pancreatic and ovarian cancer. FDA approved in 2019. Commercial partner is Thrive Earlier Detection Corp.

Datasets

There are no datasets associated with this biomarker.

Attributes
QA State: Curated
Type: Genetic
HGNC Name:

The following organs have data associated with this biomarker…

Attributes

Phase: Four
QA State: Curated
Organ-specific information for this biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

Attributes

Phase: Four
QA State: Curated
Organ-specific information for this biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

No associated publications found.

Version 5.0.2